Delivery Order SPE2DB22D9367-SPE2DB26FSU73
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $36,758.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued on September 29, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in quantities of 84 units, with a completion date of September 30, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a delivery order valued at $147,904.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The award was issued on April 24, 2025, with an ultimate completion date of April 25, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. This delivery order falls under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a $36,976.24 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The contract, which became effective on August 1, 2025, with an ultimate completion date of August 4, 2025, was issued without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The Defense Logistics Agency has awarded a firm fixed-price delivery order valued at $18,488.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a specialized pharmaceutical product delivery to support federal healthcare operations. This award carries no...
- The U.S. Defense Logistics Agency (DLA) awarded a $18,526.83 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This order for the drug Trikafta is being fulfilled under a larger single-award indefinite delivery contract (IDC), valued up to $499,999,999, awarded to DMS by the DLA. The IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
- The Defense Logistics Agency awarded a $18,474.02 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Trikafta 50-25-37.5 mg/75 mg tablets (84-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order was issued without a set-aside designation and will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $55,464.36 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. The order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and does not utilize a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $36,976.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a discrete pharmaceutical fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $55,450.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 26, 2025. The delivery order, issued under contract number 4569255033, calls for the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. DMS Pharmaceutical Group will perform the work at its Park Ridge facility, with an ultimate completion date of August 27, 2025. The...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB26FSU73Delivery Order
The Defense Logistics Agency awarded a $55,450.26 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award carries no subcontractor relationships and is funded by the Defense Logistics Agency's Medical Supply Chain division. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. This delivery order represents one of numerous recent awards under the broader $30.3 billion PPV-G GEN V acquisition strategy, positioning DMS Pharmaceutical Group as a critical supplier within the federal pharmaceutical supply chain for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $55.5k | 10/21/25 |